The company is scheduled to report results for the quarter ended Dec. 31, 2025. Analysts expect earnings of $1.41 per share on revenue of $4.35 billion—representing sequential declines from the prior ...
President and COO Karen Hanlon believes integration isn’t the endgame, but it offers a safer place to fix broken payer-provider economics. Few relationships in healthcare are under more strain right ...
Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.
Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
CCD testers are essential in electronics manufacturing for inspecting components, verifying assemblies, and ensuring product ...
The Ministry of Finance disclosed the update in a parliamentary response, noting that Phase 2 of the sandbox is focused on ...
NI LabVIEW+ Suite introduces code completion and other powerful capabilities to redefine test development productivity and ...
Rajender Reddy Muddam at SID Global Solutions develops SAMi, a gateway-agnostic API marketplace that simplifies enterprise ...
Large-scale infrastructure projects, interconnection schemes, and renewable energy developments continue to shape the ...